You read this week’s publication New Cannabis Ventures Weekly Newsletter we publish from October 2015. We no longer send them. By mail as before but we post this and all newsletters On our website hereA number
Friends,
On Friday, the S & P Dow Jones indicators announced that five shares will join the S & P / TSX composite index, including CURALAF. Since then, Curlf has earned 0.4%, rising a lot of Tuesday, but pulling yesterday. Not surprisingly, the company has a success in a press release on Monday morning, offering it to promote institutional property.
In late 2023, the Toronto Stock Exchange listed from the exchange of Canadian securities, where the market was originally entered. Terascend was the first to move to TSX, and the release moved to CAADA Conafe’s Curalaf transfer to TSX and which took place in 2023.
In two years or the way this MSOS has made their steps, no other MSOS followed. Considering that no other MSOS migrated to sleep from CSE because it did the same in the last 2023, probably doesn’t make it mean to do it. Of course, CSE has some challenges, but the bigger problem is that they are American companies. Where commercial problems are in the United States and not in Canada. Nothing against Canada but TSX list doesn’t actually change things. By the end of 2022 I called OTC as a Main potential catalystA number
In this newsletter of October 2023, I called it a waste of time To modernize TSX for American Cannabis. Looking at the price of prices, as this newsletter was published for the first degree and one of the second level, one of the nine MSOS gathered, and the rest decreased.
Readers should remember that the hemp section has decreased a lot in this moment, the NCV Global Cannabis stock index decreased by 16.6% to 6.90. The American Cannabis stock index decreased by 21.8%, and MSOS fell 34.0%. The average return of these 9 largest MSOS has even worse, but it greatly affects a murder, which has been suspended in Canada, but continues to trade on OTC.
Looking back, I would not conclude that trade exchange in Canada is generally important. One of the TSX listed shares did a little better than his peers, and one was bad. Much more than the Canadian listing drives drives the stock. I was shocked in June, when I was doing the quarterly redistribution of the Cannabis World Stock Index that the crankle was out due to insufficient trade. Only 3 MSOS qualified, resourceful and GTI and also glass home brands that trade in Canada (72.7% are increased from 10/30). In the past month, the volume of Curaleaf trade in Canada was 1,14 million shares, which is less than it trades on OTC. Perascend is 463k shares per year in the previous month, which is much less than an OTC average in one day 1 million shares. Looking at the other MSOS that trades on various exchanges in Canada, they have been a higher trade volume in OTC.
Kuralef and the tribe were so proud to discharge TSX in Canada two years ago, but it doesn’t really matter. How I used to say for several years now, what is 280e floor and OTC? I hope that 280 ends soon, but even if the hemp has resumed, there is no need to change the NASDAQ or NYSE about American hemp companies. I hope to change too.
Frankly,
Alan
New hemp enterprises publish medicine articles, as well as exclusive news. Here is what we published this last week.
To get real-time updates follow Alan X.com:Sharing a number and discover industry news along with supporters, the largest hemp group and entrepreneurs group ConnectionA number
Stay on top of some important communications of public companies by watching upcoming Cannabis Investor Calendar:A number
Based on the Houston, Alan cries out his experience as the founder of the online community 420 InvestorThe first and still the biggest decent diligent platform focused on the shares sold in the cannabis industry. Alan continues to find new ways to connect industry and facilitate its sustainable growth in the Canepuni community. Approximately New hemp enterprisesHe is responsible for content development and strategic alliances. Until the early 2013 focuses on the cannabis industry, Alan, who began his career in Wall Street, worked as more than two decades of research and portfolio. Article 650 of the Article 650 published in 2007 Looking for alphaWhere he has 70,000 followers, Alan is a frequent speaker for industry conferences and a Frequent source The media, including NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Ration | Facebook | Connection | Email
Michigan Cannabis sales in January have sharply decreased compared to a year ago, as they decreased by 15.9% consecutively. At $226.8 million, sales decreased by 8.3 percent compared to last year.
The Michigan Cannabis Regulatory Agency breaks down sales by medical and adult use, with medical sales down 43.4% year over year to $0.4 million, down 1.6% sequentially, and adult use sales down 8.2% year-over-year to $226.4 million, up 15.9% sequentially.
The state breaks down sales by category and provides pricing details by category for both medical and adult;
For adults
Medical
As supply continues to expand, prices for adult flowers have plummeted. The average price of $945 per pound in January is up 1.5% sequentially from a record low and down 11.2% from a year ago.
Michigan hemp sales are expected to grow 82.1% to $1.79 billion in 2021, 27.9% to $2.29 billion in 2022, and 33.3% to $3.06 billion in 2023. billion The program should continue to expand going forward as supply becomes more affordable and distribution expands.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
Illinois released sales figures for two months on Friday. The last time it released the data in November, the state did a major review of historical sales after a long delay, and it was updated to October. The previous report was for Cannabis for adults in May. The November document explained that the lack of data was due to the Metrc transition. “Sales tracking features in Metrc help retailers more accurately and reliably report actual sales, including all discounts and promotions at checkout. A careful review of past data shows that some initial discount prices were collected in previous months.” Here is the updated data until the end of 2025.
Statewide adult cannabis sales rose 5.6% sequentially to $116.6 million in December, up 2.2% on the day. Year-on-year growth was -23.9%, a slight improvement from November’s -26.1% growth. Here is a chart of adult sales over time:
After growing 106% in 2021, 13% in 2022 and 5% in 2023, annual sales for adults are set to grow 5.4% to $1.72 billion in 2024. In 2025, they decreased by 12.5% to $1.51 billion, which was lower than the total in 2022.
There hasn’t been an update from the state on medical cannabis in a while. The state exempts the sale separately from its medical plan, and April issue showed that sales fell 1.6% sequentially to $19.7 million, down 13.2% year over year.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
Hemp stocks, as measured by the Global Hemp Stock Index, were quite volatile in 2024 and then again in 2025 as well. Although the index rose in December, it fell on the year. In January, the indicator decreased by 10.6%, reaching 5.89.
After collapsing 21.8% in late 2024 to 6.88 in Q4, the index fell heavily in Q1 and then marginally in Q2. The global hemp stock index, which now has 27 members, gained 53.0% in the third quarter but fell 14.2% in the fourth quarter, down 4.2% for the full year.
Since its peak in February 2021, the global hemp stock index is down 93.6% from a closing high of 92.48.
The 3 strongest names in January, each an MSO, were all up more than 4%;
January’s 3 weakest names are all down more than 26%;
We will summarize the performance of the index again in a month. In April, we historically combined the two articles, and we update here the other indexes that New Cannabis Ventures continues to maintain: the American Cannabis Operator Index, the Ancillary Cannabis Index, and the Canadian Cannabis LP Index.
American Hemp Operator Index
The ACOI sank in January, falling 12.5% to 11.53. In 2025, it increased by 57.7%, reaching 13.18. The large AdvisorShares Pure US Cannabis ETF ( MSOS ) fell 14.6% in January.
The strongest stock in January was Glass House Brands, which rose 4.0%. The weakest, Trulieve (OTC: TCNNF ), fell 20.5%.
The index will have nine members in February with the removals of Ascend Wellness (OTC: AAWH ) and Grown Rogue ( GRUSF ).
Auxiliary cannabis index
Ancillary commodities lost 5.9% in January as the index fell to 10.44. In 2025, the indicator decreased by 19.5%, reaching 11.09.
January’s strongest stock was Turning Point Brands, which rose 21.8%. The weakest iPower fell by 42.0%.
In February, the index will have the same ten members.
Canadian Hemp LP Index
Canadian LPs fell 4.9% in January as the index fell to 56.13. In 2025, the indicator increased by 17.8%, reaching 59.01.
Canada’s strongest LP in January was Simply Solventless Concentrates (TSXV: HASH ), up 28.6%. Tilray Brands (TSX: TLRY ) was the weakest, down 18.0%.
In February, the index will have the same thirteen members.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
